ACCENDRA HEALTH INC (ACH) Fundamental Analysis & Valuation

NYSE:ACH • US6907321029

Current stock price

2.38 USD
+0.02 (+0.85%)
At close:
2.38 USD
0 (0%)
After Hours:

This ACH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ACH Profitability Analysis

1.1 Basic Checks

  • ACH had positive earnings in the past year.
  • ACH had a negative operating cash flow in the past year.
  • In multiple years ACH reported negative net income over the last 5 years.
  • ACH had a positive operating cash flow in 4 of the past 5 years.
ACH Yearly Net Income VS EBIT VS OCF VS FCFACH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

  • The Return On Assets of ACH (-44.89%) is worse than 88.12% of its industry peers.
  • With a decent Return On Invested Capital value of 6.54%, ACH is doing good in the industry, outperforming 65.35% of the companies in the same industry.
  • ACH had an Average Return On Invested Capital over the past 3 years of 5.25%. This is below the industry average of 8.94%.
  • The last Return On Invested Capital (6.54%) for ACH is above the 3 year average (5.25%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -44.89%
ROE N/A
ROIC 6.54%
ROA(3y)-17.83%
ROA(5y)-9.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.25%
ROIC(5y)6.87%
ACH Yearly ROA, ROE, ROICACH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200

1.3 Margins

  • Looking at the Operating Margin, with a value of 2.64%, ACH is in line with its industry, outperforming 53.47% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ACH has grown nicely.
  • Looking at the Gross Margin, with a value of 31.70%, ACH is in the better half of the industry, outperforming 60.40% of the companies in the same industry.
  • ACH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.64%
PM (TTM) N/A
GM 31.7%
OM growth 3Y31.87%
OM growth 5Y9.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.52%
GM growth 5Y25.32%
ACH Yearly Profit, Operating, Gross MarginsACH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. ACH Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ACH is creating some value.
  • Compared to 1 year ago, ACH has less shares outstanding
  • Compared to 5 years ago, ACH has more shares outstanding
  • Compared to 1 year ago, ACH has a worse debt to assets ratio.
ACH Yearly Shares OutstandingACH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
ACH Yearly Total Debt VS Total AssetsACH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • Based on the Altman-Z score of 1.32, we must say that ACH is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.32, ACH is doing worse than 61.39% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACC1.03
WACC6.36%
ACH Yearly LT Debt VS Equity VS FCFACH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • ACH has a Current Ratio of 0.58. This is a bad value and indicates that ACH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ACH's Current ratio of 0.58 is on the low side compared to the rest of the industry. ACH is outperformed by 86.14% of its industry peers.
  • ACH has a Quick Ratio of 0.58. This is a bad value and indicates that ACH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.50, ACH is doing worse than 86.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.5
ACH Yearly Current Assets VS Current LiabilitesACH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ACH Growth Analysis

3.1 Past

  • ACH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.50%.
  • Measured over the past years, ACH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.38% on average per year.
  • ACH shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -55.89%.
  • Measured over the past years, ACH shows a very negative growth in Revenue. The Revenue has been decreasing by -20.10% on average per year.
EPS 1Y (TTM)-37.5%
EPS 3Y-26.68%
EPS 5Y-15.38%
EPS Q2Q%-61.82%
Revenue 1Y (TTM)-55.89%
Revenue growth 3Y-34.78%
Revenue growth 5Y-20.1%
Sales Q2Q%-73.7%

3.2 Future

  • Based on estimates for the next years, ACH will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.21% on average per year.
  • Based on estimates for the next years, ACH will show a small growth in Revenue. The Revenue will grow by 3.83% on average per year.
EPS Next Y-41.95%
EPS Next 2Y1.03%
EPS Next 3Y8.66%
EPS Next 5Y11.21%
Revenue Next Year-6.4%
Revenue Next 2Y-1.13%
Revenue Next 3Y1.12%
Revenue Next 5Y3.83%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ACH Yearly Revenue VS EstimatesACH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
ACH Yearly EPS VS EstimatesACH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. ACH Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 2.51, which indicates a rather cheap valuation of ACH.
  • 100.00% of the companies in the same industry are more expensive than ACH, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of ACH to the average of the S&P500 Index (25.71), we can say ACH is valued rather cheaply.
  • A Price/Forward Earnings ratio of 4.32 indicates a rather cheap valuation of ACH.
  • ACH's Price/Forward Earnings ratio is rather cheap when compared to the industry. ACH is cheaper than 98.02% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.83, ACH is valued rather cheaply.
Industry RankSector Rank
PE 2.51
Fwd PE 4.32
ACH Price Earnings VS Forward Price EarningsACH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 92.08% of the companies in the same industry are more expensive than ACH, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.75
ACH Per share dataACH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.03%
EPS Next 3Y8.66%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ACH Dividend Analysis

5.1 Amount

  • ACH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ACH Fundamentals: All Metrics, Ratios and Statistics

ACCENDRA HEALTH INC

NYSE:ACH (3/13/2026, 8:08:38 PM)

After market: 2.38 0 (0%)

2.38

+0.02 (+0.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19
Earnings (Next)05-06
Inst Owners94.18%
Inst Owner Change0%
Ins Owners3%
Ins Owner Change30.94%
Market Cap181.93M
Revenue(TTM)4.72B
Net Income(TTM)-1.10B
Analysts50
Price Target3.32 (39.5%)
Short Float %11.13%
Short Ratio8.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.42%
Min EPS beat(2)-5.85%
Max EPS beat(2)6.69%
EPS beat(4)2
Avg EPS beat(4)2.81%
Min EPS beat(4)-6.28%
Max EPS beat(4)16.66%
EPS beat(8)6
Avg EPS beat(8)3.82%
EPS beat(12)10
Avg EPS beat(12)17.05%
EPS beat(16)12
Avg EPS beat(16)11.97%
Revenue beat(2)0
Avg Revenue beat(2)-20.47%
Min Revenue beat(2)-39.15%
Max Revenue beat(2)-1.79%
Revenue beat(4)0
Avg Revenue beat(4)-29.59%
Min Revenue beat(4)-75.28%
Max Revenue beat(4)-1.79%
Revenue beat(8)1
Avg Revenue beat(8)-14.92%
Revenue beat(12)3
Avg Revenue beat(12)-9.63%
Revenue beat(16)6
Avg Revenue beat(16)-6.83%
PT rev (1m)-12.16%
PT rev (3m)N/A
EPS NQ rev (1m)-169.99%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-41.75%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.51
Fwd PE 4.32
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 5.75
EPS(TTM)0.95
EY39.92%
EPS(NY)0.55
Fwd EY23.17%
FCF(TTM)-3.97
FCFYN/A
OCF(TTM)-1.33
OCFYN/A
SpS61.75
BVpS-6.03
TBVpS-23.88
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -44.89%
ROE N/A
ROCE 8.28%
ROIC 6.54%
ROICexc 8.05%
ROICexgc N/A
OM 2.64%
PM (TTM) N/A
GM 31.7%
FCFM N/A
ROA(3y)-17.83%
ROA(5y)-9.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.25%
ROIC(5y)6.87%
ROICexc(3y)5.93%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)6.65%
ROCE(5y)8.7%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y24.96%
ROICexc growth 5YN/A
OM growth 3Y31.87%
OM growth 5Y9.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.52%
GM growth 5Y25.32%
F-Score3
Asset Turnover1.93
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 5.31
Cap/Depr 93.85%
Cap/Sales 4.27%
Interest Coverage 0.92
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.5
Altman-Z 1.32
F-Score3
WACC6.36%
ROIC/WACC1.03
Cap/Depr(3y)84.12%
Cap/Depr(5y)76.01%
Cap/Sales(3y)7.98%
Cap/Sales(5y)5.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.5%
EPS 3Y-26.68%
EPS 5Y-15.38%
EPS Q2Q%-61.82%
EPS Next Y-41.95%
EPS Next 2Y1.03%
EPS Next 3Y8.66%
EPS Next 5Y11.21%
Revenue 1Y (TTM)-55.89%
Revenue growth 3Y-34.78%
Revenue growth 5Y-20.1%
Sales Q2Q%-73.7%
Revenue Next Year-6.4%
Revenue Next 2Y-1.13%
Revenue Next 3Y1.12%
Revenue Next 5Y3.83%
EBIT growth 1Y-49.91%
EBIT growth 3Y-13.99%
EBIT growth 5Y-12.24%
EBIT Next Year48.48%
EBIT Next 3Y19.83%
EBIT Next 5YN/A
FCF growth 1Y-354.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-163.03%
OCF growth 3YN/A
OCF growth 5YN/A

ACCENDRA HEALTH INC / ACH Fundamental Analysis FAQ

What is the fundamental rating for ACH stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACH.


Can you provide the valuation status for ACCENDRA HEALTH INC?

ChartMill assigns a valuation rating of 6 / 10 to ACCENDRA HEALTH INC (ACH). This can be considered as Fairly Valued.


What is the profitability of ACH stock?

ACCENDRA HEALTH INC (ACH) has a profitability rating of 4 / 10.


Can you provide the financial health for ACH stock?

The financial health rating of ACCENDRA HEALTH INC (ACH) is 1 / 10.


Is the dividend of ACCENDRA HEALTH INC sustainable?

The dividend rating of ACCENDRA HEALTH INC (ACH) is 0 / 10 and the dividend payout ratio is 0%.